Biomarker strategy for an inhibitor in bladder cancer
Discover how Tempus’ multimodal data analysis helped a biotech partner identify a key biomarker in bladder cancer. This data-driven strategy de-risked clinical development and supported a successful financing round.
May 27, 2026
Life Sciences
Case Study
Related content


